Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05535348 · ClinicalTrials.gov registry record · NA
Evaluation of a Resiliency Program for Fathers of Children and Youth With Special Health Care Needs
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05535348: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05535348 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05535348, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Based on findings from our prior trials with parents of children with learning and attentional disabilities and parents of children with autism spectrum disorder (Kuhlthau et al., 2020; Park et al., 2020; IRB approved: #:2016P001622 and 2016P002037 respectively), the investigators propose to pilot test and refine the adapted resiliency intervention (SMART-3RP) among fathers of children with special health care needs.
Interventions
- BEHAVIORAL Relaxation Response Resiliency Program for Father of CYSHCN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-05-06 |
| Est. Completion | 2022-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05535348
The ClinicalTrials.gov registry entry for NCT05535348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response Resiliency Program for Father of CYSHCN is the first listed.
NCT05535348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05535348 about?
NCT05535348 is a clinical study titled "Evaluation of a Resiliency Program for Fathers of Children and Youth With Special Health Care Needs". Based on findings from our prior trials with parents of children with learning and attentional disabilities and parents of children with autism spectrum disorder (Kuhlthau et al., 2020; Park et al., 2020; IRB approved: #:2016P001622 and 2016P002037 respectively), the investigators propose to pilot t...
What is the current status of trial NCT05535348?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-05-06. Estimated completion is 2022-10-20.
What interventions are being tested in trial NCT05535348?
The interventions under investigation include: Relaxation Response Resiliency Program for Father of CYSHCN (BEHAVIORAL).
Who is sponsoring clinical trial NCT05535348?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.